Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair [PDF]
Emmanouil Lymperis +6 more
openalex +1 more source
Impact of Heart Failure Guideline Publication on Medicare Drug Coverage Policies: A Quasi-Experimental Analysis. [PDF]
Mukhopadhyay A +10 more
europepmc +1 more source
Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis. [PDF]
Jiang N, Zhang Y, Tang Y, Tan H.
europepmc +1 more source
Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats. [PDF]
Oyama M +12 more
europepmc +1 more source
Nurse Specialising Consultation in Heart Failure: Impact on Drug Titration and Cardiovascular Events in Patients with Heart Failure and Reduced Ejection Fraction. [PDF]
Lopez-Aguilera J +15 more
europepmc +1 more source
Trends in Angiotensin Receptor-Neprilysin Inhibitor Prescribing Across Australia [PDF]
A. Narendren +3 more
openalex +1 more source
Comparative Mortality in Heart Failure on Guideline-Directed Medical Therapy Versus Malignant Cancer: A Report From a Global Federated Research Network. [PDF]
Monzo L +6 more
europepmc +1 more source
The tale of donanemab: God is in the details. [PDF]
Saido TC, Iwata N.
europepmc +1 more source

